Literature DB >> 7750500

Monocyte chemoattractant protein-1 expression and monocyte recruitment in osseous inflammation in the mouse.

P Rahimi1, C Y Wang, P Stashenko, S K Lee, J A Lorenzo, D T Graves.   

Abstract

In bone, early events in inflammation involve the production and release of primary proinflammatory cytokines, such as interleukin-1 beta. By activation of target cells, these cytokines are thought to induce a second wave of cytokines, including monocyte chemoattractant protein-1 (MCP-1). MCP-1 is a cytokine that stimulates chemotaxis of monocytes. Experiments were undertaken to examine the expression of MCP-1 in bone-associated cells in vivo. To observe in vivo expression of MCP-1, an inflammatory lesion was created in the murine mandible. Immunohistochemistry experiments using specific antibodies to MCP-1 were conducted to identify MCP-1-expressing cells in inflamed and noninflamed bone. We found that osteoblasts were the principal cells expressing MCP-1 in inflamed bone. There was little or no MCP-1 expression in noninflamed bone. Immunohistochemistry experiments were carried out to assess monocyte recruitment during osseous inflammation. The number of MCP-1-positive cells was significantly correlated to the number of monocytes/macrophages present (n = 15; r = 0.69; P < = 0.01). These in vivo results strongly suggest that MCP-1 is an important mediator involved in the recruitment of monocytes/macrophages in inflamed bone.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7750500     DOI: 10.1210/endo.136.6.7750500

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  26 in total

1.  Bacterium-dependent induction of cytokines in mononuclear cells and their pathologic consequences in vivo.

Authors:  Y Jiang; L Magli; M Russo
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Monocyte recruitment and expression of monocyte chemoattractant protein-1 are developmentally regulated in remodeling bone in the mouse.

Authors:  S Volejnikova; M Laskari; S C Marks; D T Graves
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 3.  Osteoblast responses to bacterial pathogens: a previously unappreciated role for bone-forming cells in host defense and disease progression.

Authors:  Ian Marriott
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

4.  Dendritic cell responses to surface properties of clinical titanium surfaces.

Authors:  Peng Meng Kou; Zvi Schwartz; Barbara D Boyan; Julia E Babensee
Journal:  Acta Biomater       Date:  2010-10-25       Impact factor: 8.947

5.  The zinc finger transcription factor ZXDC activates CCL2 gene expression by opposing BCL6-mediated repression.

Authors:  Jon E Ramsey; Joseph D Fontes
Journal:  Mol Immunol       Date:  2013-08-14       Impact factor: 4.407

Review 6.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

7.  Integrin and chemokine receptor gene expression in implant-adherent cells during early osseointegration.

Authors:  Omar Omar; Maria Lennerås; Sara Svensson; Felicia Suska; Lena Emanuelsson; Jan Hall; Ulf Nannmark; Peter Thomsen
Journal:  J Mater Sci Mater Med       Date:  2009-10-25       Impact factor: 3.896

8.  Monocyte chemoattractant protein 1 and interleukin-8 production in mononuclear cells stimulated by oral microorganisms.

Authors:  Y Jiang; T R Russell; D T Graves; H Cheng; S H Nong; S M Levitz
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

Review 9.  Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis.

Authors:  Antonie J H H M van Oostrom; Jeroen van Wijk; Manuel Castro Cabezas
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 10.  Osteoimmunology: cytokines and the skeletal system.

Authors:  Seoung-Hoon Lee; Tae-Soo Kim; Yongwon Choi; Joseph Lorenzo
Journal:  BMB Rep       Date:  2008-07-31       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.